Senior Manager, 340B & Market Access Pricing

Inctye; Chadds Ford Township (PA); Hybrid; USD 120,000 - 180,000; Full time

Job summary

Incyte seeks a Market Access Contracting & Pricing professional to lead 340B program strategy, compliance, and data-driven initiatives across operations. You will partner with Government Pricing, Contracting Operations, Finance, Access Strategy, Gov’t Affairs and other teams to ensure accurate insights and compliant execution.

You will develop analytics for pricing, contracting, forecast alignment, and cross-functional support for product access, formulary decisions, and lifecycle initiatives,

Qualifications

• Bachelor’s degree required; MBA or advanced degree preferred.
• 5–10+ years of experience in Market Access, Pricing, Contracting, Finance, or Analytics in the pharmaceutical/biotech industry.
• Experience with 340B program operations/excellence is strongly preferred.

Responsibilities

• Lead 340B program strategy for operations, compliance and ROI.
• Monitor 340B pricing calculations and regulatory alignment.
• Oversee data validation, disputes, and vendor coordination for 340B.
• Develop analytics to support pricing, contracting, and gross-to-net initiatives.
• Maintain dashboards and reporting tools; align forecasting with Finance.

Skills

Analytical skills

Market access knowledge

340B/Medicaid/Medicare

Excel & BI tools

Attention to detail

Communication

Multitasking

Vendor management

Influence without authority

Education

Bachelor’s degree

MBA or advanced degree preferred

Tools

Power BI

Tableau

AI

Job description

Incyte seeks a Market Access Contracting & Pricing professional to lead 340B program strategy, compliance, and data-driven initiatives across operations. You will partner with Government Pricing, Contracting Operations, Finance, Access Strategy, Gov’t Affairs and other teams to ensure accurate insights and compliant execution.

You will develop analytics for pricing, contracting, forecast alignment, and cross-functional support for product access, formulary decisions, and lifecycle initiatives,